553 CUE-100 series Immuno-STATs from concept to the clinic: Leveraging protein engineering to stimulate and selectively deliver affinity-attenuated IL-2 to antigen-specific T cells

• Saso Cemerski,
• Alex Histed,
• Natasha Girgis,
• Miguel Moreta,
• Jonathan Soriano,
• BS Luke Witt,
• Zohra Merazga,
• Fulvio Diaz,
• Fan Zhao,
• Melissa Kemp,
• Paige Ruthardt,
• Dharma Thapa,
• Anish Suri,
• Kenneth Pienta,
• Mary Simcox,
• Steven Quayle,
• John Ross

Affiliations

Saso Cemerski

Aff1 grid.417993.10000000122600793Merck Research Laboratories Boston MA USA

Alex Histed

1CUE Biopharma, Cambridge, MA, USA

Natasha Girgis

1CUE Biopharma, Cambridge, MA, USA

Miguel Moreta

1CUE Biopharma, Cambridge, MA, USA

Jonathan Soriano

1CUE Biopharma, Cambridge, MA, USA

BS Luke Witt

1CUE Biopharma, Cambridge, MA, USA

Zohra Merazga

1CUE Biopharma, Cambridge, MA, USA

Fulvio Diaz

1CUE Biopharma, Cambridge, MA, USA

Fan Zhao

1CUE Biopharma, Cambridge, MA, USA

Melissa Kemp

1CUE Biopharma, Cambridge, MA, USA

Paige Ruthardt

1CUE Biopharma, Cambridge, MA, USA

Dharma Thapa

1CUE Biopharma, Cambridge, MA, USA

Anish Suri

1CUE Biopharma, Cambridge, MA, USA

Kenneth Pienta

2Johns Hopkins University School of Medic, Baltimore, MD, USA

Mary Simcox

1CUE Biopharma, Cambridge, MA, USA

Steven Quayle

1CUE Biopharma, Cambridge, MA, USA

John Ross

1CUE Biopharma, Cambridge, MA, USA